dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2018-12-11T17:26:46Z
dc.date.available2018-12-11T17:26:46Z
dc.date.created2018-12-11T17:26:46Z
dc.date.issued2015-12-16
dc.identifierMolecules, v. 20, n. 12, p. 22534-22545, 2015.
dc.identifier1420-3049
dc.identifierhttp://hdl.handle.net/11449/177719
dc.identifier10.3390/molecules201219822
dc.identifier2-s2.0-84954348986
dc.identifier2-s2.0-84954348986.pdf
dc.identifier7927677053650819
dc.identifier8534138813417161
dc.identifier0000-0002-0057-7964
dc.identifier0000-0003-1574-681X
dc.description.abstractThe aim of this study was to construct a nanostructured lipid system as a strategy to improve the in vitro antibacterial activity of copper(II) complexes. New compounds with the general formulae [CuX2(INH)2]·nH2O (X = Cl- and n = 1 (1); X = NCS- and n = 5 (2); X = NCO- and n = 4 (3); INH = isoniazid, a drug widely used to treat tuberculosis) derived from the reaction between the copper(II) chloride and isoniazid in the presence or absence of pseudohalide ions (NCS- or NCO-) were synthesized and characterized by infrared spectrometry, electronic absorption spectroscopy, electron paramagnetic resonance (EPR) spectroscopy, elemental analysis, melting points and complexometry with 2,2′,2″,2″-(Ethane-1,2-diyldinitrilo)tetraacetic acid (EDTA). The characterization techniques allowed us to confirm the formation of the copper(II) complexes. The Cu(II) complexes were loaded into microemulsion (MEs) composed of 10% phase oil (cholesterol), 10% surfactant [soy oleate and Brij® 58 (1:2)] and 80% aqueous phase (phosphate buffer pH = 7.4) prepared by sonication. The Cu(II) complex-loaded MEs displayed sizes ranging from 158.0 ± 1.060 to 212.6 ± 1.539 nm, whereas the polydispersity index (PDI) ranged from 0.218 ± 0.007 to 0.284 ± 0.034. The antibacterial activity of the free compounds and those that were loaded into the MEs against Staphylococcus aureus ATCC® 25923 and Escherichia coli ATCC® 25922, as evaluated by a microdilution technique, and the cytotoxicity index (IC50) against the Vero cell line (ATCC® CCL-81™) were used to calculate the selectivity index (SI). Among the free compounds, only compound 2 (MIC 500 μg/mL) showed activity for S. aureus. After loading the compounds into the MEs, the antibacterial activity of compounds 1, 2 and 3 was significantly increased against E. coli (MIC's 125, 125 and 500 μg/mL, respectively) and S. aureus (MICs 250, 500 and 125 μg/mL, respectively). The loaded compounds were less toxic against the Vero cell line, especially compound 1 (IC50 from 109.5 to 319.3 μg/mL). The compound 2- and 3-loaded MEs displayed the best SI for E. coli and S. aureus, respectively. These results indicated that the Cu(II) complex-loaded MEs were considerably more selective than the free compounds, in some cases, up to 40 times higher.
dc.languageeng
dc.relationMolecules
dc.relation0,855
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAntibacterial activity
dc.subjectCopper(II) complexes
dc.subjectEscherichia coli
dc.subjectNanostructured lipid system
dc.subjectStaphylococcus aureus
dc.titleA nanostructured lipid system as a strategy to improve the in Vitro antibacterial activity of copper(II) complexes
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución